News
NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH
Are you interested in licensing or co-developing SARS-CoV-2 targeting antibodies? Investigators at the National Cancer Institute (NCI) have isolated a panel of anti-receptor binding domain (RBD) single domain antibodies (also called ‘nanobodies’) from camel single domain (VHH) phage display
IRP Senior Investigator and Inventor Dr. Peter Choyke has been elected to the National Academy of Medicine (NAM). Dr. Choyke is the Director of the National Cancer Institute’s Molecular Imaging Branch. He was elected for his work on improving diagnosis and treatment through imaging technologies for
The National Center for Advancing Translational Sciences (NCATS) Office of Strategic Alliances is hosting a f ederal technology transfer workshop focused on measuring impact, innovation, and efficiencies. This event is intended for technology transfer professionals, policy makers, and innovators to